PROBLEM TO BE SOLVED: To provide new compositions for treating hemorrhoid such as a suppository an ointment for external use an ointment for injection a cream and gel stably keeping a vasoconstrictor effective for all symptoms of bleeding pain itching and inflammation by compounding a vasoconstrictor a local anesthetic and an antiphlogistic. SOLUTION: The composition for treating hemorrhoid comprises (a) at least one vasoconstrictor selected from a group consisting of tetrahydrozoline hydrochlo...

The invention relates to the field of the pharmaceutical industry and medicine and can be used for the production and application of pharmaceutical compositions having vasoconstricting anticongestant and anti-inflammatory activity in cases of acute rhinitis inflammatory processes of the maxillary sinuses nosebleeds and conjunctivitis. The problem of the invention consists in producing a pharmaceutical composition on the basis of the preparation naphazoline by introducing mineral substances into ...

FIELD: medicine pharmaceutics.SUBSTANCE: invention relates to field of medicine namely to ophthalmology and can be applied for treatment of different diseases of eyes. Eye drops contain methylene blue diphenhydramine hydrochloride naphazoline hydrochloride hydroxypropylmethylcellulose boric acid polyvinylpyrrolidone and distilled water in defined ratio of components.EFFECT: invention ensures non-toxic and non-irritating anti-inflammatory anti-infectious anti-allergic action.4 ex

ABSTRACT - 600243 The disclosure relates to an agent consisting of theobromine and a decongestant as a combined preparation for use in a therapy of cough wherein the agent is manufactured for administration by an oral route wherein the decongestant is selected from ephedrine levmetamfetamine naphazoline oxymetazoline phenylephrine phenylpropanolamine propylhexedrine pseudoephedrine synephrine and tetrahydrozoline and wherein the decongestant preferably pseudoephedrine is to be administered in a ...

PROBLEM TO BE SOLVED: To provide a flunisolide-containing composition for mucosal application having excellent storage effectiveness and antiallergic action. SOLUTION: The composition for mucosal application is prepared by combining and formulating (A) flunisolide with (B) a vasoconstrictor and (C) a chelating agent. Naphazoline tetrahydrozoline or a salt thereof is preferably used as the vasoconstirictor (B). COPYRIGHT: (C)2013JPO&INPIT

The present invention describes a topic ophthalmic formulation useful for treating ocular diseases particularly in infectious processes related to corneal inflammatory processes caused by micotic or bacterial infections. The formulation may contain a ratio of ketoconazol naphazoline hydrochloride sulphate and gentamycin sulphate in amounts optimised for streamlining the action of the antimicotic drug. The ophthalmic solution of the present invention is a broad-spectrum antibiotic for treating im...

PROBLEM TO BE SOLVED: To provide an ophthalmic composition in which viscosity reduction due to light irradiation is suppressed while containing a carboxyvinyl polymer. SOLUTION: The ophthalmic composition contains the carboxyvinyl polymer and -aminocaproic acid or a pharmaceutically acceptable salt thereof and has viscosity of 200-100000 mPa s. Further the composition preferably contains naphazoline or a pharmaceutically acceptable salt thereof. The composition is further preferably contains bo...

Stable compositions comprising ketotifen or a ketotifen salt and methods of preparing such compositions are provided. The pH of the compositions remains at less than about 5 during storage. The methods comprise preparing pharmaceutical compositions comprising ketotifen or a ketotifen salt and adjusting their pH to less than 5 thus slowing the changes of the active ingredients.

Stable compositions comprising ketotifen or a ketotifen salt and methods of preparing such compositions are provided. The pH of the compositions remains at less than about 5 during storage. The methods comprise preparing pharmaceutical compositions comprising ketotifen or a ketotifen salt, and adjusting their pH to less than 5, thus slowing the changes of the active ingredients.